Application 219531
- Type
- NDA
- Sponsor
- BRILLIAN PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SDAMLO | AMLODIPINE BESYLATE | FOR SOLUTION;ORAL | EQ 2.5MG BASE/BOT | Yes | Yes |
| 002 | SDAMLO | AMLODIPINE BESYLATE | FOR SOLUTION;ORAL | EQ 5MG BASE/BOT | Yes | Yes |
| 003 | SDAMLO | AMLODIPINE BESYLATE | FOR SOLUTION;ORAL | EQ 10MG BASE/BOT | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N219531-001 | SDAMLO | AMLODIPINE BESYLATE | EQ 2.5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | |
| N219531-002 | SDAMLO | AMLODIPINE BESYLATE | EQ 5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | |
| N219531-003 | SDAMLO | AMLODIPINE BESYLATE | EQ 10MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N219531-001 | SDAMLO | EQ 2.5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N219531-002 | SDAMLO | EQ 5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N219531-003 | SDAMLO | EQ 10MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N219531-001 | SDAMLO | EQ 2.5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N219531-002 | SDAMLO | EQ 5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N219531-003 | SDAMLO | EQ 10MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N219531-001 | SDAMLO | EQ 2.5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N219531-002 | SDAMLO | EQ 5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N219531-003 | SDAMLO | EQ 10MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N219531-001 | SDAMLO | EQ 2.5MG BASE/BOT | FOR SOLUTION / ORAL | RLD | 2025-07-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N219531-002 | SDAMLO | EQ 5MG BASE/BOT | FOR SOLUTION / ORAL | RLD | 2025-07-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N219531-003 | SDAMLO | EQ 10MG BASE/BOT | FOR SOLUTION / ORAL | RLD | 2025-07-24 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N219531-001 | SDAMLO | EQ 2.5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N219531-002 | SDAMLO | EQ 5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N219531-003 | SDAMLO | EQ 10MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N219531-001 | SDAMLO | EQ 2.5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N219531-002 | SDAMLO | EQ 5MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N219531-003 | SDAMLO | EQ 10MG BASE/BOT | FOR SOLUTION / ORAL | RLD, RS | 2025-07-24 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine Besylate | AMLODIPINE BESYLATE | Coupler LLC | 5af8493b-2b73-859c-e063-6394a90a4620 | 2026-09-08 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | GSMS, Incorporated | 9c0f83f4-06ad-4bb1-a8e3-dcac43b840cf | 2026-09-01 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | NCS HealthCare of KY, LLC dba Vangard Labs | 6efc0ef6-0424-44fc-a9ea-eb30c3b83239 | 2026-09-01 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | QPharma, Inc. | 5866d1ee-631d-d09e-e063-6294a90abe01 | 2026-08-20 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | American Health Packaging | 79f41cd2-6d58-4b03-8b0c-ca91398bc1a9 | 2026-08-17 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Redpharm Drug | 58d2fbed-3904-3e31-e063-6294a90af21d | 2026-08-12 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Redpharm Drug | 58336a97-807a-2859-e063-6294a90ad338 | 2026-08-04 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | REMEDYREPACK INC. | 58a67272-c4c7-4e2c-85a5-9d39034d12c3 | 2026-07-27 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Major Pharmaceuticals | edf9b22c-e37e-4b4e-8a64-20bb036c7d2d | 2026-07-27 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE 2.5 mg | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | 1080fcea-a5da-499d-a855-690c13559071 | 2026-07-17 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | NuCare Pharmaceuticals, Inc. | 4926f00c-ee19-3e10-e054-00144ff88e88 | 2026-07-17 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | REMEDYREPACK INC. | 4ad016ec-e158-4325-9f45-4460cf78dd98 | 2026-07-16 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | REMEDYREPACK INC. | d09173a1-5e3c-4c86-8c7c-15238925ef50 | 2026-07-01 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | REMEDYREPACK INC. | a6fa364c-3ad6-4bf9-b9ee-5ec3b1a7eb55 | 2026-06-24 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Unit Dose Solutions, Inc. | 5467eee5-1519-7859-e063-6294a90afed1 | 2026-06-16 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Safecor Health LLC | 572bc798-c3d9-4fe2-98be-8e1913bda8f3 | 2026-06-12 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | China Resources Saike Pharmaceutical Co., Ltd. | 3518853a-4c5b-4161-a178-8da7f656f009 | 2026-06-08 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Proficient Rx LP | 61cb7f91-d1f6-40bd-98a3-c461098a20d9 | 2026-06-01 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Bryant Ranch Prepack | f546047f-1cc6-4bbe-a67b-b5c9815b89af | 2026-05-22 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | ST. MARY'S MEDICAL PARK PHARMACY | b2d5cccd-e5ff-2909-e053-2a95a90a9773 | 2026-05-22 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.